OvuCon

Company Overview

Snapshot

Founded in May 2015 by Simon Dotan and Gidon Zundelevich, OvuCon operated with 1–10 employees. The company ceased operations in November 2019.

Business overview

OvuCon developed an over-the-counter medical device designed to accurately predict ovulation, assisting couples in conceiving by identifying the woman's fertile period. The company's core technology utilized a proprietary sensor and algorithms to predict ovulation and provide a five-day fertile window, accessible via a mobile phone. OvuCon operated within the Health Tech & Life Sciences sector, specifically targeting the digital healthcare and medical devices markets.

Company Intelligence Q&A

What is OvuCon's primary product?

OvuCon developed an over-the-counter medical device, the Personal Fertility Assistant, designed to accurately predict ovulation for couples trying to conceive.

When was OvuCon founded and by whom?

OvuCon was founded in May 2015 by Simon Dotan and Gidon Zundelevich.

What was the operational status of OvuCon?

OvuCon ceased operations in November 2019.

What was a key early development for OvuCon's technology?

In November 2015, Priority Aviation Inc. announced the licensing of OvuCon's Personal Fertility Assistant product technology.

What was the core technology behind OvuCon's device?

OvuCon's device was powered by a proprietary sensor and algorithms designed to accurately predict ovulation and provide a five-day fertile window, accessible via a mobile phone.